Tuesday, March 31, 2026
CN
  • About
  • Advertise
  • Careers
  • Contact
Money Compass
  • Home
  • Financial News
  • Investment News
  • Other News
    • Bursa News
    • Government News
    • Listing Companies News
    • Oversea Financial & Investment News
  • Interviews
    • Features Interviews
    • Corporate Interviews
  • Financial & Investment Articles
  • PR Newswire
  • Login
No Result
View All Result
Money Compass
Home PR Newswire

LabConnect Launches SampleGISTICS® 2.0 to Digitize Clinical Trial Sample Capture

Money Compass by Money Compass
March 31, 2026
in PR Newswire
0
LabConnect Launches SampleGISTICS® 2.0 to Digitize Clinical Trial Sample Capture
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Smartphone-based solution streamlines site workflows and enables real-time visibility at the sample level

RALEIGH, N.C., March 31, 2026 /PRNewswire/ — LabConnect, a global provider of central laboratory services and functional service provider solutions for clinical trials, today announced the launch of SampleGISTICS® 2.0, an application that enables clinical research sites to scan, record and transmit participant sample information. The application replaces LabConnect’s long-standing digital pen technology, modernizing sample collection and data entry at the site level.

Related posts

Harbour City Shopping Mall and Bandai Namco Asia Launch the first-ever flagship event “Bandai Namco Asia Journey in Hong Kong”

Harbour City Shopping Mall and Bandai Namco Asia Launch the first-ever flagship event “Bandai Namco Asia Journey in Hong Kong”

March 31, 2026
Harbour City Shopping Mall and Bandai Namco Asia Launch the first-ever flagship event “Bandai Namco Asia Journey in Hong Kong”

Harbour City Shopping Mall and Bandai Namco Asia Launch the first-ever flagship event “Bandai Namco Asia Journey in Hong Kong”

March 31, 2026
LabConnect Logo

Drawing on insights from millions of samples collected across global clinical trials, SampleGISTICS 2.0 is designed to eliminate paper-based requisitions, manual data entries and disconnected courier processes. These persistent challenges can lead to lost samples, delayed shipments and limited operational oversight.

“SampleGISTICS 2.0 is the result of our more than two decades of experience managing decentralized clinical trials across our global network of laboratories, couriers and operations,” said Wes Wheeler, chief executive officer of LabConnect. “That level of expertise and integration made it possible to develop a new application designed specifically for clinical trials by digitizing sample capture at the collection point.”

The mobile application gives sites a fast, intuitive way to manage sample collection, requisitioning and shipment tracking from a smartphone or tablet. Features such as barcode scanning, multilingual support and offline functionality enable consistent performance across diverse site environments while supporting same-day data collection and improved protocol compliance.

Unlike traditional workflows that rely on periodic status updates, SampleGISTICS 2.0 provides real-time visibility into sample location, status and stability from collection through laboratory intake. Application-guided workflows aligned with study protocols help reduce data entry errors and ensure proper kit usage, supporting downstream shipment and laboratory processes.

“SampleGISTICS 2.0 simplifies how sites handle study visit and participant data at the point of collection, securely transferring it into LabConnect’s validated LIMS environment,” said Charles Castano, chief technology officer at LabConnect. “By leveraging technology to streamline data capture at the site, we can significantly reduce queries and gain visibility into samples arriving close to expiration windows that require priority processing. This also reduces manual steps, provides immediate sample traceability, enables real-time data capture, and supports faster, more reliable laboratory results.”

For more information, visit LabConnect.com.

About LabConnect
LabConnect is a global provider of technology-enabled central laboratory services and functional service provider solutions for pharmaceutical, biotechnology and contract research organizations. The company connects laboratories, logistics, technology and scientific expertise through a decentralized laboratory network model to support clinical trials worldwide. Learn more at LabConnect.com.

Logo – https://mma.prnewswire.com/media/2611513/LabConnect_Logo.jpg

Cision View original content:https://www.prnewswire.com/apac/news-releases/labconnect-launches-samplegistics-2-0-to-digitize-clinical-trial-sample-capture-302729562.html

SOURCE LabConnect

​ 

Previous Post

Shinebed International Showcases the Future of Comfort at Market Week 2026

Next Post

Eightco (NASDAQ: ORBS) Reports Total Holdings of $326 Million, Includes Nearly 280 Million Worldcoin and Over 11,000 ETH

Next Post
Eightco (NASDAQ: ORBS) Reports Total Holdings of $326 Million, Includes Nearly 280 Million Worldcoin and Over 11,000 ETH

Eightco (NASDAQ: ORBS) Reports Total Holdings of $326 Million, Includes Nearly 280 Million Worldcoin and Over 11,000 ETH

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

BROWSE BY CATEGORIES

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire

BROWSE BY TOPICS

2018 League Balinese Culture Bali United Budget Travel business Champions League Chopper Bike Doctor Terawan industrial Istana Negara Malaysia Market Stories National Exam net zero emissions targets 2025 Renewable energy Visit Bali

Recent News

  • Harbour City Shopping Mall and Bandai Namco Asia Launch the first-ever flagship event “Bandai Namco Asia Journey in Hong Kong”
  • Harbour City Shopping Mall and Bandai Namco Asia Launch the first-ever flagship event “Bandai Namco Asia Journey in Hong Kong”
  • Guiyang hosts 20th Guizhou Tourism Industry Development Conference

Category

  • Blog
  • Bursa News
  • Corporate Interviews
  • Features Interviews
  • Financial & Investment Articles
  • Financial News
  • Government News
  • Investment News
  • Listing Companies News
  • Oversea Financial & Investment News
  • PR Newswire
  • About
  • Advertise
  • Careers
  • Contact

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Features Interviews
  • Government News
  • Financial News
  • Investment News
  • Listing Companies News
  • Corporate Interviews
  • Bursa News
  • Financial & Investment Articles
  • Oversea Financial & Investment News

Copyright © 2024 Money Compass Media (M) Sdn Bhd. All Rights Reserved